Related Experiment Video
Updated: Dec 30, 2025
08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
10.4K
Cyclopamine-Paclitaxel-Containing Nanoparticles: Internalization in Cells Detected by Confocal and Super-Resolution
Gaia Fumagalli1, Davide Mazza2, Michael S Christodoulou1
1Dipartimento di Chimica-Università degli Studi di Milano, Via Golgi 19, 20133 Milano (Italy).
Chempluschem
|January 25, 2020
Summary
Novel fluorescent nanoparticles loaded with cyclopamine and paclitaxel demonstrate combined cancer treatment efficacy. These self-assembled nanoparticles allow for visualization of cellular uptake using advanced microscopy techniques.
Area of Science:
- Nanotechnology
- Cancer Therapeutics
- Cell Biology
Background:
- Cancer treatment often requires combination therapies for improved efficacy.
- Nanoparticle drug delivery systems offer potential for targeted and enhanced therapeutic outcomes.
- Visualizing cellular internalization is crucial for understanding drug delivery mechanisms.
Purpose of the Study:
- To develop self-assembled hetero-nanoparticles co-delivering cyclopamine and paclitaxel.
- To create fluorescent nanoparticles for tracking cellular uptake.
- To evaluate the combined efficacy of these nanoparticles against cancer cell lines.
Main Methods:
- Self-assembly of hetero-nanoparticles incorporating cyclopamine and paclitaxel.
- Inclusion of a dye-squalene conjugate to impart fluorescence.
- Confocal microscopy and super-resolution dSTORM imaging for cellular internalization studies.
- In vitro efficacy testing on three distinct cancer cell lines.
Main Results:
- Successfully generated fluorescent nanoparticles containing both cyclopamine and paclitaxel.
- Demonstrated effective cellular internalization of the nanoparticles.
- Observed combined therapeutic efficacy of the nanoparticle formulation against tested cancer cell lines.
- Confirmed nanoparticle uptake via confocal and dSTORM microscopy.
Conclusions:
- Self-assembled hetero-nanoparticles offer a promising platform for co-delivery of chemotherapeutic agents.
- Fluorescent labeling enables visualization and confirmation of nanoparticle cellular uptake.
- The combined drug delivery approach shows potential for enhanced cancer treatment strategies.
